Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
CAMP vs OABI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
OABI Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 6–2 Matrix Metrics)
OABI Overall Winner
6-Pillar Tally: CAMP 0 – 5 OABI (1 Tie)
Matrix Metrics: CAMP 2 – 6 OABI
As of Nov 17, 2026, OmniAb, Inc. (OABI) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CAMP carries a Unified Composite Score of 43.9/100 (HOLD) at $3.95 (N/M Forward P/E, -991.8% operating margin), whereas OABI carries 56.2/100 (HOLD) at $5.01 (N/M Forward P/E, -92.9% operating margin).
- Growth vs. Quality Trade-Off: OABI earns the overall head-to-head edge with a stronger Unified Composite Score (56.2/100 HOLD vs. CAMP 43.9/100 HOLD) and 1.24β · 58% Vol risk profile, whereas CAMP leads top-line expansion (+138.9% YoY revenue growth, N/M PEG, and 0 of 6 institutional pillars) for higher-beta growth mandates.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About CAMP vs OABI
CAMP
CAMP4 Therapeutics Corporation Common Stock
$3.95
+2.33% 1D
Market Cap
$238.5M
TTM Revenue
$5.3M
Forward P/E
N/M
Beta / 30D Vol
1.34β · 94% Vol
Unified Composite Score
43.9
HOLD
Tech 34.0
Fund 40.0
Flow 50.0
Mom 40.0
Weinstein Technical Phase
Neutral · Hold
OABI
Head-to-Head Winner
OmniAb, Inc. Common Stock
$5.01
+2.45% 1D
Market Cap
$716.2M
TTM Revenue
$40M
Forward P/E
N/M
Beta / 30D Vol
1.24β · 58% Vol
Unified Composite Score
56.2
HOLD
Tech 50.0
Fund 51.0
Flow 54.0
Mom 50.0
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (CAMP 0 – 5 OABI)
1. Valuation Multiples
OABI
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
26.6x
17.7x
2. Growth & Scale
OABI
Revenue Growth (YoY)
+138.9%
+78.3%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$5.3M
$40M
Market Cap
$238.5M
$716.2M
3. Profitability & Quality
OABI
Gross Margin
N/A
97.7%
Operating Margin
-991.8%
-92.9%
Net Profit Margin
0.0%
-108.1%
Return on Equity (ROE)
-146.1%
-16.5%
4. Balance Sheet & Cash Flow
OABI
Cash Generation (TTM)
-$26M
$2.4M
Cash Flow Margin
N/A
5.9%
Net Cash / Leverage
$97M Net Cash
$4.7M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
OABI
Options Structure Phase
UNCLASSIFIED
SURGE
Current IV / %ile
N/A (N/A)
83.3% (10th %ile)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Neutral
NEUTRAL · Markup
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Biotechnology Operator
Biotechnology Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: CAMP (2) vs OABI (6)| Institutional Metric | CAMP | OABI | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $238.5M | $716.2M | OABI | |
| Trailing P/E Ratio | N/M | N/M | Tie | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | +138.9% | +78.3% | CAMP | |
| Operating Margin (TTM) | -991.8% | -92.9% | OABI | |
| Net Profit Margin | 0.0% | -108.1% | CAMP | |
| Return on Equity (ROE) | -146.1% | -16.5% | OABI | |
| 52-Week Range Position | 22% ($3–$8) | 89% ($1–$5) | OABI | |
| Beta / 30D Volatility | 1.34β · 94% Vol | 1.24β · 58% Vol | OABI | |
| Unified Institutional Score | 43.9 / 100 (HOLD) | 56.2 / 100 (HOLD) | OABI | |
| Trailing 12M Revenue (USD) | $5.3M | $40M | Scale | |
| Gross Profit Margin (TTM) | N/A | 97.7% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 26.6x EV/Rev | N/M PEG · 17.7x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$26M ($97M Net Cash) | $2.4M ($4.7M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
CAMP +18.98 pp
3M Horizon
OABI +34.62 pp
6M Horizon
OABI +116.21 pp
1Y Horizon
OABI +224.81 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CAMP Revenue | OABI Revenue | CAMP Op. Margin | OABI Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2021 | N/A | $30M | N/A | -102.5% | OABI |
| FY2022 | N/A | $60M | N/A | -45.1% | OABI |
| FY2023 | $0M | $30M | -14822.6% | -203.2% | OABI |
| FY2024 | $0M | $30M | -8142.3% | -282.3% | OABI |
| FY2025 | $0M | $20M | -1502.4% | -369.5% | OABI |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
CAMP
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact CAMP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
OABI
SURGE
Current IV
83.3%
IV Percentile
10th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact OABI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
CAMP Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
OABI Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ CAMP vs OABI Key Questions & Quantitative Answers
As of Nov 17, 2026, OmniAb, Inc. (OABI) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CAMP carries a Unified Composite Score of 43.9/100 (HOLD) at $3.95 (N/M Forward P/E, -991.8% operating margin), whereas OABI carries 56.2/100 (HOLD) at $5.01 (N/M Forward P/E, -92.9% operating margin). Growth vs. Quality Trade-Off: OABI earns the overall head-to-head edge with a stronger Unified Composite Score (56.2/100 HOLD vs. CAMP 43.9/100 HOLD) and 1.24β · 58% Vol risk profile, whereas CAMP leads top-line expansion (+138.9% YoY revenue growth, N/M PEG, and 0 of 6 institutional pillars) for higher-beta growth mandates.
OABI leads the Growth & Scale pillar: CAMP posts +138.9% YoY revenue growth and +0.0% YoY earnings growth on $5.3M TTM revenue (N/A gross margin, -991.8% operating margin), compared with OABI at +78.3% YoY revenue growth and +0.0% YoY earnings growth on $40M TTM revenue (97.7% gross margin, -92.9% operating margin). Across the 5-period historical trajectory (FY2021 to FY2025), CAMP cumulative revenue shifted N/A while OABI shifted -33.3%. In operating R&D and SG&A reinvestment, CAMP deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for OABI.
OABI screens cheaper on headline valuation multiples. CAMP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 26.6x EV/Revenue (unreported FCF margin), whereas OABI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 17.7x EV/Revenue (5.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CAMP (-146.1% ROE) versus OABI (-16.5% ROE) capital efficiency.
In options market volatility and institutional positioning, CAMP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.34β · 94% Vol realized risk). By comparison, OABI carries 83.3% implied volatility (10th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (1.24β · 58% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
OABI vs CAMP · Reverse Pair
CAMP vs HLIT
· Sector Peer
CAMP vs ADTN
· Sector Peer
CAMP vs DGII
· Sector Peer
OABI vs OBIO
· Sector Peer
OABI vs LRMR
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem